Western study of arsenic trioxide (As2O3) in patients with relapsed and/or refractory acute promyelocytic leukemia

被引：0
|
作者：
Soignet, SL [1 ]
Maslak, P [1 ]
Chen, YW [1 ]
Calleja, E [1 ]
Pandolfi, PP [1 ]
Scheinberg, DA [1 ]
Warrell, RP [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
675
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [31] A phase I/II trial of arsenic trioxide for relapsed and refractory-acute promyelocytic leukemia.
    Westervelt, P
    Adkins, D
    Brown, R
    Goodnough, LT
    Khoury, H
    Rush, C
    Lojka, T
    Miller, G
    DiPersio, JF
    BLOOD, 1998, 92 (10) : 219B - 219B
  • [32] COST-EFFECTIVENESS OF ARSENIC TRIOXIDE IN THE TREATMENT OF RELAPSED/REFRACTORY ACUTE PROMYELOCYTIC LYMPHOMA LEUKEMIA IN CANADA
    Lachaine, J.
    Mathurin, K.
    Barakat, S.
    VALUE IN HEALTH, 2014, 17 (03) : A84 - A84
  • [33] Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission Therapies
    Kazuyuki Shigeno
    Kensuke Naito
    Naohi Sahara
    Miki Kobayashi
    Satoki Nakamura
    Sinya Fujisawa
    Kaori Shinjo
    Akihiro Takeshita
    Ryuzo Ohno
    Kazunori Ohnishi
    International Journal of Hematology, 2005, 82 : 224 - 229
  • [34] Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: Updated outcomes of the phase II study and postremission therapies
    Shigeno, K
    Naito, K
    Sahara, N
    Kobayashi, M
    Nakamura, S
    Fujisawa, S
    Shinjo, K
    Takeshita, A
    Ohno, R
    Ohnishi, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (03) : 224 - 229
  • [35] Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
    Fox, Elizabeth
    Razzouk, Bassem I.
    Widemann, Brigitte C.
    Xiao, Shaun
    O'Brien, Michelle
    Goodspeed, Wendy
    Reaman, Gregory H.
    Blaney, Susan M.
    Murgo, Anthony J.
    Balis, Frank M.
    Adamson, Peter C.
    BLOOD, 2008, 111 (02) : 566 - 573
  • [36] Arsenic trioxide metabolism in patients with acute promyelocytic leukemia
    Khan, Mohammad T.
    Tariq, Sara
    Ghiuzeli, Cristina M.
    Styblo, Miroslav
    Saunders, Jesse
    Calabro, Anthony
    Kohn, Nina
    Budman, Daniel
    Allen, Steven
    Devoe, Craig
    CANCER RESEARCH, 2017, 77
  • [37] Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
    Akihiro Tomita
    Hitoshi Kiyoi
    Tomoki Naoe
    International Journal of Hematology, 2013, 97 : 717 - 725
  • [38] Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
    Tomita, Akihiro
    Kiyoi, Hitoshi
    Naoe, Tomoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (06) : 717 - 725
  • [39] Arsenic trioxide in relapsed or refractory Acute Promyelocytic Leukemia - An NCI special exception (compassionate use) program.
    Shalabi, AM
    Fallavollita, A
    Cheson, BD
    Edwards, M
    Plante, M
    Huntley, C
    Phalen, K
    Mungo, AJ
    BLOOD, 2001, 98 (11) : 596A - 596A
  • [40] Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide
    O Galm
    U Fabry
    R Osieka
    Leukemia, 2000, 14 : 343 - 344
12345